Close

legal cannabis

Due-Diligence Is Key for Betting on Cannabis in Nevada

Nevada and cannabis

The Nevada cannabis market is unique among states with legal recreational cannabis regimes. The role of tourism plays a big role in shaping retail trends. The concentration of sales in urban centers stands apart. And the state’s regulatory framework offers benefits and challenges for cannabis companies and investors. Since July […]

Read More

Cannabis Retail Opportunities Abound

Cannabis Retail BDS Analytics

Cannabis is perhaps the most exciting retail opportunity to hit U.S. markets in decades. The lucrative combination of rapid sales growth, an ever-expanding customer base and government-enforced protection against mass-retail has resulted in a unique market that is unlikely to be replicated anytime soon. For more than a decade, State […]

Read More

California’s Cannabis Industry is Ready to Realize Its Full Potential

BDS Analytics California: Lessons from the World's Largest Cannabis Market

Inspired by the Cannabis Intelligence Briefing Series Report: California: Lessons from the World’s Largest Cannabis Market Analysis of the emerging California adult-use market, detailed in the new Cannabis Intelligence Briefing by Arcview Market Research and BDS Analytics: “California: Lessons from the World’s Largest Cannabis Market”, tells the story of the […]

Read More

Will Global Legal Cannabis Spending Exceed $40 Billion by 2024?

Consumer spending on legal cannabis worldwide reached $10.9 billion in 2018. This number is especially significant considering the variables at play: the California market transition from lightly regulated medical-only to fully regulated adult-use; the maturation of first-in, adult-use markets in Colorado and Washington; and the lackluster rollout of legal adult-use […]

Read More

Pharmaceutical Versus Dispensary Cannabinoids Competition

pharmaceuticals vs dispensaries | BDS Analytics

Epidiolex Approval Queues Up Pharmaceutical Versus Dispensary Cannabinoids Competition Pharmaceutical cannabinoids have been around since the 1980s in synthetic or semi-synthetic form for the treatment of nausea related to cancer, and anorexia related to both cancer and AIDS. The FDA approved GW Pharmaceuticals’ Epidiolex in 2018 marking the first time […]

Read More

Welcome to the East Coast: Three Takeaways From the 2019 Seed to Sale Show

BDS Analytics | Seed to Sale Show 2019

Welcome to the East Coast: Three Takeaways From the 2019 Seed to Sale Show This year, the NCIA Seed to Sale Show moved from West to East. The third annual event, historically held in Denver, took place in Boston last week and drew a crowd of exhibitors and attendees eager […]

Read More

Subscribe to Our Newsletter